The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...
Hosted on MSN3mon
Roche Gets Approval for Vabysmo PFS in EU for Three Retinal DiseasesThe PFS delivers the same drug as the currently available 6.0 mg Vabysmo vials in an alternative, ready-to-use format. Per Roche, Vabysmo PFS will be the EU’s first and only prefilled syringe ...
Asian News International on MSN7d
Sovereign Pharma Achieves Prestigious EU Approval for Aseptic and Terminally Sterilized Injectable ProductsSovereign Pharma, a leader in high-quality injectable manufacturing, proudly announces its milestone: EU approval for aseptic ...
The available presentations are 45 mg/0.5 mL PFS, 90 mg/mL PFS, 45 mg/0.5 mL vial, and 130 mg/26 mL vial. Shreehas Tambe, CEO & Managing Director, Biocon Biologics Ltd, said: "The launch of ...
Sovereign Pharma achieves EU approval for aseptic and terminally sterilized injectable products: Our Bureau, Bengaluru Wednesday, March 19, 2025, 14:45 Hrs [IST] Sovereign Pharma, ...
including vials, ampoules, cartridges, and pre-filled syringes (PFS) for both liquid and lyophilized formulations. This achievement is a significant step in the company's commitment to quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback